Andalan Sakti Primaindo Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Andalan Sakti Primaindo Tbk trades at Rp535 (market cap 340.91B, 1.84M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Andalan Sakti Primaindo Tbk is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Andalan Sakti Primaindo Tbk is more actively traded (1.84M versus 214.9K). Which is the better fit depends on your goals.
| ASPI | OBAT | |
|---|---|---|
Market Cap | 340.91B | 164.65B |
Volume | 1.84M | 214.9K |
Lot | 18.36K | 2.15K |
Turnover | 934.18M | 51.97M |
Average Price | 508.81 | 241.85 |
Value | 934.18M | 51.97M |
Indicative Equilibrium Price | 535 | 240 |
Indicative Equilibrium Volume | 348 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Andalan Sakti Primaindo Tbk. ("the Company") was established based on the Notarial Deed of Saniwati Suganda, S.H., No.81 dated 13 November 2012. Entiry parent is PT Andalan Sakti Inti.
Read more on ASPI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →